Formidable Asset Management’s Aptose Biosciences APTO Stock Holding History
Bought
Maintained
Sold
Other funds holding APTO
Formidable Asset Management's APTO Position: Q2 2023 in Review
Formidable Asset Management sold out of Aptose Biosciences (APTO) in Q2 2023, closing a stake of 200 shares — an estimated $58K sold.
Formidable Asset Management first reported a position in APTO in Q1 2022 and held it in 3 quarters. The position peaked at $122K in Q1 2022. 24 funds tracked by Wall St. Rank hold APTO as of Q2 2023.
- Formidable Asset Management reported no remaining Aptose Biosciences position as of Q2 2023 after selling out during the quarter.
- Formidable Asset Management sold 200 Aptose Biosciences shares in Q2 2023, an estimated $58K.
- Formidable Asset Management first reported a position in Aptose Biosciences in Q1 2022 and held it in 3 quarters.
- Formidable Asset Management's Aptose Biosciences position peaked at $122K in Q1 2022.
- 24 funds tracked by Wall St. Rank held Aptose Biosciences as of Q2 2023.
Based on Formidable Asset Management's 13F filing for Q2 2023, filed 15 Aug 2023.